Here, we found that expression levels of GRZMA and PRF1 genes were lower in patients with a high ppScore compared to patients with a low ppScore, potentially suggesting the suppression of CTLs in these patients and implicating that the identified gene signature could be utilized as a potential predictive prognostic biomarker in CRC patients. Here, PRF1 is linked to colorectal carcinoma.